Researchers have developed a new therapy which selectively targets immune cells responsible for allergic responses. A pilot study was also carried out on mice and it was noted that the therapy demonstrated 100 % success in preventing allergic responses without causing noticeable side effects.

Researchers have made use of a novel AI-based method called Drfold to enhance the accuracy of RNA models by more than 70 percent when compared to traditional approaches.

A new study has revealed that advanced tools and more experimental studies are urgently required to understand the impact of extreme heat on urban health and wellbeing in the UK.

Researchers have revealed that the digital twin technology could be used for personalizing the treatment of patients suffering from brain tumors. The impact of this technology could be revolutionary for the healthcare sector.

New research introduces a novel small molecule drug, showing remarkable potential in pre-clinical studies to not only alleviate symptoms but also repair nerve damage. This innovative approach, represents a major leap towards clinical application, offering new hope for those affected by multiple sclerosis.

The EU-funded Resilience project aims to prevent heart failure in cancer patients who need anthracyclines. The project is testing a promising preventive treatment called remote ischaemic conditioning in lymphoma patients at risk for anthracycline cardiotoxicity. If the results are positive, heart failure could be significantly reduced in cancer survivors.

Researchers have found that a new bio-inspired drug has the potential to restore the effectiveness of immune cells in fighting cancer. The research could be a game changer for cancer patients.

US scientists have developed “Anthrobots,” tiny robots made from human tracheal cells, capable of moving and stimulating neuron growth in damaged areas in lab settings. These cell-based robots, varying in size and shape, are self-assembling and demonstrate healing properties, advancing the field of regenerative medicine.

Researchers at the University of Graz and the Helmholtz Institute for Pharmaceutical Research Saarland (Hips) have succeeded in developing a strategy for synthesising active pharmaceutical compounds from wood waste. The advantage: they do not require any harmful starting materials or by-products.

New findings reveal the likely reason why certain chemotherapies are effective for many patients. Importantly, they also help explain why attempts to find new chemo drugs based solely on stopping cellular division have been so disappointing.